text:
EX-99.3
7
a11-30612_1ex99d3.htm
EX-99.3
Exhibit 99.3
News Release
Ecolab Inc.
370 Wabasha Street North
St. Paul, Minnesota 55102
FOR IMMEDIATE RELEASE
Michael J. Monahan 651.293.2809
ECOLAB RAISES CASH DIVIDEND 14 PERCENT
20
th
consecutive annual dividend rate increase
Ecolab has paid dividends for 75 consecutive years
ST. PAUL, Minn., December 1, 2011 - The Board of Directors of Ecolab Inc. today increased the company's quarterly cash dividend by 14% to $0.20 per common share, to be paid January 17, 2012, to shareholders of record at the close of business on December 20, 2011. This results in a new indicated annual cash dividend of a record $0.80 per share for 2012, and represents Ecolab's 20th consecutive annual dividend rate increase. Ecolab has paid cash dividends on its common stock for 75 consecutive years. Ecolab last increased its dividend in December 2010.
Commenting on the increase, Douglas M. Baker, Jr., Ecolab's Chairman and Chief Executive Officer said, "We are pleased to once again increase our dividend and continue our strong cash dividend record following our merger with Nalco. We have achieved this outstanding dividend record through our excellent business model and strong financial position, and we believe our recent actions have strengthened our growth prospects, cash flow and ability to deliver superior shareholder returns going forward".
With 2011 annualized sales of $11 billion and more than 38,000 employees, Ecolab Inc. (NYSE: ECL) is the global leader in water, hygiene and energy technologies and services that provide and protect clean water, safe food, abundant energy and healthy environments. Ecolab delivers comprehensive programs and services to the food, energy, healthcare, industrial and hospitality markets in more than 160 countries. More Ecolab news and information is available at www.ecolab.com
.
-more-
Cautionary Statements Regarding Forward-Looking Information
This news release contains various "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements concerning the indicated annual cash dividend for 2012 and our outlook for further growth. These statements, which represent Ecolab's expectations or beliefs concerning various future events, are based on current expectations that involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. We caution that undue reliance should not be placed on forward-looking statements, which speak only as of the date made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
More detailed information about risks and uncertainties that may affect our operating results and business performance may be found in our and, prior to December 1, 2011, Nalco's filings with the Securities and Exchange Commission, including under Item 1A of reports filed on Form 10-K and Form 10-Q, and include the vitality of the markets we serve; the impact of worldwide economic factors such as the worldwide economy, credit markets, interest rates and foreign currency risk fluctuations in raw material and delivered product costs; our ability to develop competitive advantages through value, innovation and customer support; restraints on pricing flexibility due to contractual obligations; pressure on operations from consolidation of customers and vendors; our ability to promptly and effectively integrate the businesses of Ecolab and Nalco and to achieve the cost savings and synergies we anticipate from the Nalco acquisition within the expected time frame or at all; the Nalco acquisition may involve unexpected costs, unexpected liabilities or unexpected delays; the ability to acquire other complementary businesses and to effectively integrate such businesses; the costs and effects of complying with laws and regulations relating to the environment, including evolving climate change standards, and to the manufacture, storage, distribution, sale and use of our products, as well as to the conduct of our business generally, including employment and labor laws; the occurrence of litigation or claims; acts of war, terrorism or hostilities, natural or man-made disasters, water shortages or severe weather conditions which impact our markets; our ability to attract and retain high caliber management talent; and other risks or uncertainties reported from time to
2
time in our filings with the Securities and Exchange Commission.
###
(ECL-D)
3

text: Ecolab Inc.

text: ECOLAB

text: Ecolab

text: Ecolab Inc.

text: Ecolab

text: Ecolab

text: Ecolab

text: Ecolab

text: Ecolab Inc.

text: Ecolab

text: Ecolab

text: Ecolab

text: Ecolab


dataset: buster

text:
EX-99.1
3
hadv_ex991.htm
PRESS RLEASE
Blueprint
Exhibit
99.1
Health Advance Inc. Announces Signing of Definitive Agreement to
Acquire Hantian Labs
LAS
VEGAS, October 14, 2016 - Health Advance Inc. (the
"Company") (OTC Pinks: HADV) is pleased to announce
that on October 13, 2016, the Company signed a definitive agreement
("Definitive Agreement") to acquire 100% interest in
Hantian Labs Limited, a private UK corporation (Hereinafter
referred to as "Hantian"). As a result of the
acquisition, Health Advance will also control 99% of JT Hantian LLC
representing the revenue arm of Hantian. Pursuant to the Definitive
Agreement, on closing the Health Advance will issue 1.5 common
shares of the Company for each share of Hantian Labs outstanding at
the time of closing representing the purchase price of Hantian.
Accordingly, the Company's issued and outstanding number of
common shares will increase from 24,520,000 shares to 39,520,000
shares. In addition, Hantian shall undertake to raise a minimum
financing of $250,000 for marketing of Hantian's product line
prior to the closing of the transaction.
On
closing the Company will appoint Mr. Christian Diesveld as a
director of Health Advance. Mr. Diesveld is currently the Managing
Director of Hantian. Prior to co-founding Hantian Labs, Christian
spent a total of sixteen years within the public marketplace,
specializing in the marketing and financing of exchange-listed
companies to all facets of the international investment community.
Additionally, Mr. Diesveld spent the previous ten years in the role
of Managing Director at Peritus Capital, a Toronto based Investor
Relations firm. Having worked closely with corporations in the
pharmaceutical, technology and resource sectors, Christian brings
an abundance of experience and contacts from a wide range of
sectors throughout the global marketplace.
Hantian
Labs (
www.hantianlabs.com)
is an
emerging global leader in anti-ageing and vitality nutraceutical
products. Developed by a team of research scientists, athletes and
beauty professionals, the Hantian line of tablets uses
state-of-the-art age reversal technology to diminish the signs of
ageing, whilst enhancing, enriching and extending the lives of
their consumers. Products, including GHBurn, Alpha Elite and
Revitamar, are made at Hantian's GMP ISO 9001 and Informed
Sports certified facility in the United Kingdom with the strictest
quality standards. Hantian products are Medicines & Healthcare
Products Regulatory Agency (MHRA) approved. Hantian also has
licenses issued by the Minister of Health for Canada, issued under
the authority of section 7 of the Natural Health Products
Regulations, for its products GHBurn and Alpha Elite.
GHBurn is a scientifically proven powerful natural precursor to HGH
(Human Growth Hormone), the body's master hormone. It was
uniquely designed to enhance the body's hormonal system,
which begins to deteriorate after the age of thirty. It increases
testosterone production, lean muscle mass, enhances energy,
alertness and libido, while decreasing fat production and cravings.
GHBurn provides muscles with increased energy at the cellular level
enhancing athletic performance and ability. Used daily, the unique
proprietary blend of ingredients regulates male hormones, which in
effect halts and more importantly reverses the aging
process.
Alpha Elite is widely considered one of the ultimate
supplements to combat natural
testosterone deterioration and enhance overall male performance. It
stimulates and intensifies all vigorous activity for the Alpha
Elite male. Being stimulant free, it safely elevates your
testosterone to new levels, whilst increasing your lean
muscularity, vascularity and libido.
Revitamar is a powerful age defying supplement proven to banish
wrinkles and restore a youthful appearance. The pioneering
restorative blend of antioxidants, minerals and marine properties
stimulates youthful radiant skin and softens fine lines. Founded in
the age old notion of "health through water", the high
concentration of marine collagen and sea kelp naturally restore
elasticity, diminishes pigmentation and protect cells from
oxidative damage while hyaluronic acid, zinc and vitamin C, secures
moisture, creates fullness, decreases the appearance of cellulite
and alleviates joint pain.
"We
are eager to advance Health Advance through continued expansion.
The addition of Christian Diesveld to our board of directors brings
leadership, extensive financing experience, and vast knowledge of
the nutraceutical sector, all critical to our success,"
stated President and CEO,Jordan Starkman. "We are thrilled to
have entered into the nutraceutical sector and remain committed to
creating shareholder value for Health Advance's
shareholders.
Certain statements in this document that are not historical facts
are "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995. Such
statements may be identified by the use of words such as
"anticipate, "believe", "expect,"
"future", "may", "will,"
"would", "should", "plan,"
"projected", "intend", and similar
expressions. Such forward-looking statements, involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, performance or achievements of Health Advance Inc.
to be materially different from those expressed or implied by such
forward-looking statements. The Company's future operating
results are dependent upon many factors, including but not limited
to: (i) the Company's ability to obtain sufficient capital or
a strategic business arrangement to fund its current operational or
expansion plans; (ii) the Company's ability to build and
maintain the management and human resources and infrastructure
necessary to support the anticipated growth of its business; (iii)
competitive factors and developments beyond the Company's
control; and (iv) other risk factors discussed in the
Company's periodic filings with the Securities and Exchange
Commission, which are available for review at
www.sec.gov
under "Search for Company
Filings.
For
more information, please contact:
Health
Advance Inc.
Jordan
Starkman, CEO
www.healthadvanceinc.com
1-800-854-7970
3651
Lindell Road, Suite D155, Las Vegas, NV 89103
1-800-854-7970

label: organization

text: Health Advance Inc.

text: Hantian Labs

text: Health Advance Inc.

text: Hantian Labs Limited

text: Health Advance

text: JT Hantian LLC

text: Health Advance

text: Hantian Labs

label: person

text: Christian Diesveld

text: Health Advance

text: Hantian Labs

text:
Hantian
Labs

text: Health Advance

text: Christian Diesveld

text: Jordan Starkman

text: Health Advance

text: Health Advance Inc.

text:
Health
Advance Inc.

text:
Jordan
Starkman

source_dataset: expertai/BUSTER

annotation_scope: BUSTER company-role spans plus reviewed organization, fund, person, and event additions with document-local surface projection; annotations remain non-exhaustive


text:
EX-99.1
3
exhibit991.htm
PRESS RELEASE
Silver Dragon Resources Inc. - Press Release - Prepared By TNT Filings
Inc.
PRESS RELEASE
Headline
Silver Dragon Resources Inc. Signs Definitive Asset Purchase Agreement to
Acquire Majority Interest in Chinese Company, Sanhe Sino-Top Resources and
Technologies, Ltd.
Toronto, Canada - (PRIMEZONE) - March 21, 2006
- Silver Dragon Resources Inc. (OTC BB:
SDRG.OB
-
News
) today
announced the signing of a Definitive Asset Purchase Agreement with Sino Silver
Corp. ("Sino Silver") and Sanhe Sino-Top Resources and Technologies, Ltd.
("Sino-Top") to acquire 100% of Sino Silver's assets. Sino Silver's main asset
consists of 60% of the equity in Sino-Top, a Chinese company which holds the
exploration and mining rights to several properties and a mine located in the Erbaohuo Silver District in Northern China. In addition, Sino-Top is party to
strategic agreements with various parties including the North China Geological
Exploration Bureau (NCGEB). Silver Dragon also receives the right to increase
its equity interest in Sino-Top up to 70%. The Agreement is subject to receipt
of the administrative consent of the local Provincial Department of Commerce in
China.
The purchase price for the assets of Sino
Silver is US$650,000 and 4,000,000 restricted shares of common stock of the
Company. According to the terms of the acquisition, US$150,000 was paid today,
with US$100,000 payable on May 20, 2006, and US$400,000 payable once all
administrative procedures are complete and consents are obtained in China.
Silver Dragon has also agreed to advance US$250,000 to Sino-Top by March 30,
2006, prior to receipt of the administrative consent in China, in order to
contribute to Sino-Top's operations.
The terms of this Agreement replace and supersede the terms of
a previous venture agreement entered into between Silver Dragon and Sino Silver
on April 14, 2005.
"We are pleased to have signed this Agreement
with Silver Dragon Resources", commented David Bikerman, President and Chief
Executive Officer of Sino Silver. "We believe this is an exciting opportunity
for both the shareholders of Sino Silver and Silver Dragon at a time when silver
assets in China, specifically within the Erbaohuo Silver District, are extremely
valuable."
"Silver Dragon's acquisition of Sino Silver's
assets will be a significant milestone for our company as we continue to build a
diversified portfolio of silver mining interests around the world", commented
Marc Hazout, President and Chief Executive Officer of Silver Dragon. "Our
immediate objective is to focus on development plans for the existing properties
and mines in the Erbaohuo Silver District, which is a historic silver reserve
with three producing silver mines, one of which is the Bairen Daba, the second
largest silver mine in China. I will be traveling to
China next week to meet with representatives of China International Trust and
Investment Corporation (CITIC) and to review other opportunities presented to us
by our strategic partners in China".
Silver Dragon Resources Inc. is a mining and
metal company focused on the exploration, acquisition, development and operation
of silver mines in proven silver districts globally. Silver Dragon's objective
is to acquire silver mining assets that contain promising exploration targets,
have highly-leveraged, out-of-the-money silver deposits, and/or are producing
properties with significant untapped exploration potential. For more
information, please visit
www.silverdragonresources.com
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995: The statements contained herein which
are not historical are forward-looking statements that are subject to risks and
uncertainties that could cause actual results to differ materially from those
expressed in the forward-looking statements, including, but not limited to,
certain delays beyond the company's control with respect to market acceptance of
new technologies or products, delays in testing and evaluation of products, and
other risks detailed from time to time in the Company's filings with the
Securities and Exchange Commission.
Contact:
Silver Dragon Resources Inc.
Marc Hazout, (416) 661-4989
info@silverdragonresources.com

text: Silver Dragon Resources Inc.

text: Silver Dragon Resources Inc.

text: Silver Dragon Resources Inc.

text:
Sino Silver
Corp.

text: Sino Silver

text: Sino Silver

text: Sino Silver

text:
Sino
Silver

text: Sino Silver

text: David Bikerman

text: Sino Silver

text: Sino Silver

text: Sino Silver

text: Marc Hazout

text: Silver Dragon Resources Inc.

text: Silver Dragon Resources Inc.

text: Marc Hazout


text:
EX-99.1
3
a07-29006_1ex99d1.htm
EX-99.1
Exhibit
99.1
ATS Corporation Completes
Acquisition of Number Six Software, Inc.
MCLEAN, VA - (BUSINESSWIRE) - November 12, 2007, McLean, VA. ATS
Corporation ("ATSC") (OTCBB:ATCT.OB), a leading information technology company
that delivers innovative technology solutions to federal, state, and local
government organizations, today announced that it has completed the previously
announced acquisition of Number Six Software, Inc. ("Number Six"), a provider
of application development and information technology consulting to both
government and commercial customers.
This acquisition supports ATSC's strategic growth plan to broaden its
information technology services expertise and add new customers in each of ATSC's
target sectors.
ATSC
Chairman, President and Chief Executive Officer, Dr. Edward Bersoff, stated,
"We are pleased to complete the acquisition of Number Six. This transaction adds scale and customers in
both government and commercial markets.
It also establishes a strong platform for growth in 2008 and beyond and
demonstrates our ability to accomplish our priority initiatives".
ATSC
expects Number Six to generate annual revenues of approximately $33 million in
2007 with EBITDA (earnings before interest, taxes, depreciation and
amortization) unadjusted for potential synergies of approximately $3.6
million. EBITDA is not a recognized term
under U.S. generally accepted accounting principles and does not purport to be
an alternative to net income as a measure of operating performance or to cash
flows from operating activities as a measure of liquidity.
Further,
ATSC expects approximately 15% in revenue growth for Number Six in 2008, with
$1.5 to $2.0 million in potential EBITDA growth and synergies over the next 12
to 18 months through a combination with ATSC operations. As a result, ATSC expects the transaction to
be accretive to earnings in 2008.
About Number Six Software, Inc.
Number
Six employs approximately 175 professionals, delivering information technology
governance, software process improvement and custom application development to
both commercial and government customers.
Headquartered in Vienna, Virginia with six satellite offices in the
southeast and mid-western United States, the Company brings together the teams,
methods and processes necessary to resolve risk, define requirements and manage
assets throughout the system lifecycle.
Additional information about Number Six can be found at www.numbersix.com.
About ATS Corporation and Advanced Technology Systems,
Inc.
ATS Corporation operates through its subsidiaries, Advanced Technology
Systems, Inc., Reliable Integration Services, and Appix, Inc.
Advanced Technology Systems, Inc. ("ATS") is a leading provider of
systems integration and application development, IT infrastructure management and
strategic IT consulting services to U.S. federal government agencies. Since its founding in 1978, ATS has been
recognized for its custom software development and software integration
capabilities and its deep domain expertise in federal government financial,
human resource and data management systems.
ATS has built and implemented over 100 mission-critical systems for
clients.
ATS' financial management software expertise assists clients preparing
for the government's increased financial accountability standards. ATS' data management systems expertise allows
clients to increase efficiency with better human resource and case management
tracking capabilities, while also allowing them to organize and track
information easily. Additionally, ATS'
IT outsourcing capabilities provide ATS with an opportunity to develop
long-term value added partnerships with clients that allow end-users and
government agencies to focus on core mission priorities, while reducing
expenditures on systems management.
In addition, ATSC leverages its IT services, management consulting, and
software and systems development solutions expertise into financial
institutions, insurance companies and government sponsored enterprises through
a wholly owned subsidiary, Appix, Inc. ("Appix"). Appix is one of the largest providers of
outsourced professional services at Fannie Mae and currently serves many
Fortune 500 financial services and insurance companies. Additional information about Appix may be
found at www.appix.com.
Any statements in this press release about future expectations, plans,
and prospects for ATSC, including statements about the estimated value of the
contract and work to be performed, and other statements containing the words "estimates,"
"believes", "anticipates", "plans", "expects", "will", and similar expressions,
constitute forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995.
In particular, this press release contains forward-looking statements
about our acquisition of Number Six.
Actual results of the above-described transaction may differ materially
from those indicated by such forward-looking statements as a result of various
important factors, including the following:
our ability to successfully integrate the acquired business; our
dependence on our contracts with federal government agencies for the majority
of our revenue; our dependence on our GSA schedule contracts; our position as a
prime contractor on government-wide acquisition contracts to grow our business;
and other factors discussed from time to time in our filings with the
Securities and Exchange Commission. In
addition, the forward-looking statements included in this press release
represent our views as of November 9, 2007.
We anticipate that subsequent events and developments will cause our
views to change. However, while we may
elect to update these forward-looking statements at some point in the future,
we specifically disclaim any obligation to do so. These forward-looking statements should not be
relied upon as representing our views as of any date subsequent to November 9,
2007.
Additional information about ATSC and ATS may be found at www.atsva.com.
Contact:
ATS Corporation
Dr. Edward H. Bersoff
Chairman, President and Chief Executive Officer
(703) 506-0088
or
Joann O'Connell
Vice President, Investor Relations
(703) 506-0088
or
Public Relations
David Knowles, 301-924-0330 x25
Source: ATS Corporation

text: ATS Corporation

text: Number Six Software, Inc.

text:
ATS
Corporation

text: Number Six Software, Inc.

text: Number Six

text: Edward Bersoff

text: Number Six

text: Number Six

text: Number Six

text: Number Six Software, Inc.

text:
Number
Six

text: Number Six

text: ATS Corporation

text: ATS Corporation

text: Number Six

text: ATS Corporation

text: Edward H. Bersoff

text: ATS Corporation


text:
EX-99.1
2
voxx-ex991_27.htm
EX-99.1
voxx-ex991_27.htm
FOR IMMEDIATE RELEASE
Exhibit 99.1
VOXX INTERNATIONAL CORPORATION CLOSES ON SALE OF ITS PULHEIM REAL ESTATE AND WILL CONTINUE TO OPERATE ITS GERMAN ACCESSORIES BUSINESS
ORLANDO, FL. - October 2, 2019
- VOXX International Corporation (NASDAQ: VOXX), a leading manufacturer and distributor of automotive and consumer technologies for global markets, announced today that on September 30, 2019, it closed on the sale of its Pulheim real estate and received net proceeds of approximately $9.7 million (based on the Euro to US dollar conversion rate at that time) after payment of the outstanding mortgage and transactional costs.
Additionally, on September 30, 2019, VOXX received a notice of rescission from HF Company with respect to its previously announced definitive agreement to sell VOXX German Accessory Holdings GmbH.
The Company previously announced on June 12, 2019 that it had reached a definitive agreement to sell VOXX German Accessory Holdings GmbH, which comprised the operations of Oehlbach Kabel GmbH ("Oehlbach") and Schwaiger GmbH ("Schwaiger") to HF Company for approximately $19.0 million, based on the Euro to US dollar conversion at that time.
The notice of rescission received by the Company was due to HF Company's inability to secure bank financing for the implementation of the transaction. As such, VOXX International Corporation will retain the Oehlbach and Schwaiger operations and will continue to market and distribute their diverse and innovative accessory offerings. Further, the Company believes that based on the changes previously announced to realign these units into one operating entity, it will be in a stronger position to improve bottom-line performance of an already profitable unit. Additionally, the rescission notice received includes the purchase option by VOXX German Holdings GmbH to HF Company relating to the real estate leased by Schwaiger.
Pat Lavelle, President and Chief Executive Officer of VOXX International Corporation, stated, "We are pleased to close on the sale of our real property in Pulheim and strengthen our balance sheet. We took action in fiscal 2019 to reorganize our international business and consolidate the operations of Schwaiger and Oehlbach into one operating entity. While the proposed accessories transaction would have further strengthened our balance sheet, we are satisfied to keep these strong European brands as they have been consistent earnings contributors in the past, and we expect that will continue in the future. Our strategy to potentially divest and acquire assets remains intact and our #1 focus remains to position VOXX for improved and sustainable profitability in the years ahead".
About VOXX International Corporation
VOXX International Corporation (NASDAQ: VOXX) has grown into a worldwide leader in many automotive and consumer electronics and accessories categories, as well as premium high-end audio. Today, VOXX International is a global company, with an extensive distribution network that includes power retailers, mass merchandisers, 12-volt specialists and most of the world's leading automotive manufacturers. The Company has an international footprint in Europe, Asia and Latin America, and a growing portfolio, which comprises over 30 trusted brands. For additional information, please visit our website at
www.voxxintl.com
.
Safe Harbor Statement
Except for historical information contained herein, statements made in this release constitute forward-looking statements and thus may involve certain risks and uncertainties. All forward-looking statements made in this release are based on currently available information and the Company assumes no responsibility to update any
such forward-looking statements. The following factors, among others, may cause actual results to differ materially from the results suggested in the forward-looking statements. The factors include, but are not limited to: statements with respect to the anticipated results of the proposed transaction; the proposed transaction's anticipated benefits to the Company; the anticipated closing of the proposed transaction; and, other risk factors described in the Company's annual report on Form 10-K for the fiscal year ended February 28, 2019 which was filed with the SEC on May 14, 2019, as amended on Form 10-K/A filed on May 30, 2019, and other filings made by the Company from time to time with the SEC. The factors described in such SEC filings include, without limitation: the Company's ability to realize the anticipated results of its business realignment; cybersecurity risks; risks that may result from changes in the Company's business operations; our ability to keep pace with technological advances; significant competition in the automotive, premium audio and consumer accessories businesses; our relationships with key suppliers and customers; quality and consumer acceptance of newly introduced products; market volatility; non-availability of product; excess inventory; price and product competition; new product introductions; foreign currency fluctuations; and restrictive debt covenants.
Investor & Media Relations Contact:
Glenn Wiener, GW Communications (for VOXX)
Tel: 212-786-6011 / Email:
gwiener@GWCco.com

text: VOXX INTERNATIONAL CORPORATION

text: VOXX International Corporation

text: VOXX International Corporation

text: Pat Lavelle

text: VOXX International Corporation

text: VOXX International Corporation

text: VOXX International Corporation


text:
EX-99..1
5
exhibit4.htm
EX-99..1
EX-99..1
FOR IMMEDIATE RELEASE
GUILFORD PHARAMCEUTICALS COMPLETES
SALE AND LEASEBACK AND RECEIVES $19.4 MILLION IN NET PROCEEDS
BALTIMORE, MD
, December 17, 2004 - Guilford Pharmaceuticals Inc. (Nasdaq: GLFD) today announced
that it has completed a sale and leaseback of its facilities in Baltimore, Maryland with BioMed
Realty Trust, Inc., a real estate investment trust focused on acquiring, owning, leasing and
developing laboratory and office space for life science, biotechnology and pharmaceutical
companies. The net proceeds of this transaction to Guilford were $19.4 million. In connection
with this transaction, Guilford has entered into a long-term lease with BioMed for the facilities.
Guilford intends to use the proceeds for general corporate purposes, including providing additional
working capital to support its development pipeline and the continued advancement of the Company's
AQUAVAN® Injection development program, currently in Phase III clinical testing.
About Guilford
Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and
commercialization of proprietary drugs that target the hospital and neurology markets. Presently,
Guilford markets two commercial products, GLIADEL
®
Wafer (polifeprosan 20 with
carmustine implant), for the treatment of certain types of brain tumor in combination with
radiation and surgery, and AGGRASTAT
®
Injection (tirofiban hydrochloride), a
glycoprotein GP IIb/IIIa receptor antagonist, for the treatment of acute coronary syndrome (ACS).
Guilford's product pipeline includes AQUAVAN
®
Injection, an investigational
sedative/anesthetic drug, and drugs for treating peripheral nerve injury. For full prescribing
information, please visit
www.guilfordpharm.com
under Products / Marketed Products.
###
Contact:
Guilford Pharmaceuticals Inc.
Stacey Jurchison 410.631.5022
jurchisons@guilfordpharm.com
Internet addresses: www.guilfordpharm.com

text: GUILFORD PHARAMCEUTICALS

text: Guilford Pharmaceuticals Inc.

text:
BioMed
Realty Trust, Inc.

text: Guilford

text: Guilford

text: BioMed

text: Guilford

text: Guilford

text: Guilford Pharmaceuticals Inc.

text: Guilford

text: Guilford

text: Guilford Pharmaceuticals Inc.


text:
EX-99.1
3
dex991.htm
PRESS RELEASE
Press Release
Exhibit 99.1
REMEC Sells Electronic Manufacturing Services Business
SAN DIEGO, CA - July 5, 2005 - REMEC, Inc. (NASDAQ: REMC) announced today that it
has completed the sale of its Electronic Manufacturing Services ("EMS") business unit to Veritek Manufacturing Services, LLC ("Veritek") and Samjor Family Limited Partnership ("Samjor"). The EMS business unit, located
primarily in Escondido California, is engaged in the contract manufacturing of customer designed electronic products, including the assembly of surface mount interconnect printed circuit boards, and the production and sale of completely assembled
and tested electronic products. Veritek and Samjor paid $19 million in cash for the EMS business, subject to certain post-closing adjustments. REMEC expects taxes and transaction expenses to be approximately $6 million.
Thomas Waechter, President and Chief Executive Officer of REMEC, stated, "This
transaction strengthens our cash position and continues our strategy of delivering value to REMEC shareholders. The EMS business unit and its dedicated people have been important contributors to the REMEC team. We appreciate their past efforts and
believe that they will contribute to the success of Veritek".
Brian Kahn,
Veritek's Managing Director, stated, "Veritek is pleased to provide the opportunity for the talented management team at REMEC's Electronic Manufacturing Services business unit to grow their business as a standalone entity. Under the
continued leadership of Keith Butler, Veritek will now be able to focus 100% of its energy on serving its customers' electronic manufacturing needs".
About the Companies
REMEC, Inc. is a designer and manufacturer of high frequency subsystems used in the transmission of voice, video and data traffic over wireless communications networks.
Veritek Manufacturing Services, LLC is a contract manufacturer of customer
designed electronic products, including the assembly of surface mount interconnect printed circuit boards, and the production and sale of completely assembled and tested electronic products.
Forward-looking Statements
Statements in this press release that are not historical are forward-looking statements,
which involve known and unknown risks and uncertainties. Actual results could differ materially from those implied by such forward-looking statements due to a variety of factors, including, general and industry economic conditions, competition,
development factors, operating costs and other risks and uncertainties that are detailed from time to time in our filings with the Securities and Exchange Commission.
###

text: REMEC

text: REMEC

text: Veritek Manufacturing Services, LLC

text: Samjor Family Limited Partnership

text: REMEC

text: Thomas Waechter

text: REMEC

text: REMEC

text: REMEC

text: REMEC

text: REMEC

text: Veritek Manufacturing Services, LLC


text:
EX-99.1
11
d857405dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
Apergy and ChampionX Complete Merger to Create the New ChampionX
.
Creates a Global Leader in Production-Optimization Solutions
.
Newly combined company now named "ChampionX Corporation"; ticker symbol "CHX"
.
Integration expected to deliver $75 million in cost synergies plus additional revenue growth
opportunities
.
Transaction immediately deleverages the combined company's balance sheet
.
Two new board members will join seven existing Apergy board members to form the new ChampionX Corporation
board of directors
THE WOODLANDS, TX, June 3, 2020 - ChampionX Corporation, formerly known as Apergy Corporation
("ChampionX" or "the Company") (NYSE: APY) announced today the completion of the merger of the businesses of Apergy Corporation and ChampionX Holding Inc., the former upstream energy business of Ecolab Inc. In association with
this transaction, Apergy Corporation has changed its name to ChampionX Corporation, and beginning tomorrow its shares of common stock will trade on the New York Stock Exchange under the symbol "CHX".
"Today we are proud to launch ChampionX, a company that will be an essential player and long-term winner in the oil and gas industry", said
Sivasankaran "Soma" Somasundaram, President and Chief Executive Officer of ChampionX. "Our combined company will be a strong and resilient organization with a broad geographic footprint, high quality customer base, and significant
recurring revenue. "The combination enables us to bring together a unique platform with
best-in-class
product lines in artificial lift, production chemicals, and
digital technology delivered with superior service capabilities to provide the full spectrum of production-optimization solutions to our customers. Our
7,000-plus
talented employees around the world will
continue to work collaboratively to solve problems for our customers. Financially, the successful completion of this transaction results in a company with sustainable strong free cash flow generation and has an immediate deleveraging benefit for the
Company's balance sheet. We will immediately implement our plans to capture the $75 million in expected cost synergies, plus additional revenue growth opportunities made possible by the complementary product, geography, and customer
profiles of the combined organization.
"I am delighted to welcome Heidi Alderman and Stu Porter to the ChampionX board of directors. They are both
highly qualified individuals and we will greatly benefit from their experience and guidance. We are excited about our future as ChampionX, and as we begin our journey we will be guided by our purpose of "improving lives" supported by our
foundation of a strong culture and operating principles".
The transaction resulted in existing ChampionX Holding Inc. equityholders owning
approximately 62% of ChampionX on a fully diluted basis, with Apergy equityholders prior to the merger owning approximately 38% of ChampionX on a fully diluted basis.
1
New Board Members
In addition to the seven directors which formed the board of directors of Apergy Corporation prior to the completion of the transaction, ChampionX appointed
Heidi Alderman and Stuart Porter to its board of directors.
Heidi S. Alderman
Heidi Alderman is the former Senior Vice President, Intermediates of BASF Corporation (a global chemical manufacturing company), a position she held from 2016
until her retirement in 2019. Prior to this role, Ms. Alderman held the positions of Senior Vice President, North American Petrochemicals from 2011 to 2016; Senior Vice President, North American Procurement from 2008 to 2011; Vice President,
Functional Polymers from 2005 to 2008; and Business Director, Polymers from 2003 to 2005, all at BASF SE.
Ms. Alderman's
39-year
career in chemicals manufacturing brings a unique and valuable perspective to the Board. She also holds a bachelor's degree in chemical engineering from Stevens Institute of Technology and a
master's degree in chemical engineering from Drexel University, providing a depth of expertise for the Company's expanded business. Ms. Alderman has held various positions in business, operations, research, procurement, product and
marketing management at BASF, Air Products and Chemicals Inc. and Rohm and Haas, in addition to completing the University of Pennsylvania Wharton Management Program in business administration, providing a global business management perspective to
the Board.
Ms. Alderman has served on the Board of Olin Corporation since 2019 where she is a member of the Directors and Corporate Governance
Committee.
Stuart Porter
Stu Porter founded Denham
Capital in 2004 and is a Managing Partner as well as Denman's Chief Executive Officer and Chief Investment Officer. Mr. Porter holds a Bachelor of Arts from the University of Michigan and a Master of Business Administration from the
University of Chicago Booth School of Business.
Mr. Porter brings three plus decades of experience evaluating, investing and advising companies all
along the energy value chain. In his current and previous roles, he has overseen the management of 40 upstream, midstream and oilfield service companies representing in excess of $3.5 billion of invested capital. Additionally, Mr. Porter
has significant global experience, managing offices in London and Perth Australia for Denham Capital as well as deploying investment capital across more than 25 portfolio companies in Africa, Australasia, and North and South America. In
Mr. Porter's previous roles as a founding partner of Sowood Capital Management LP and Vice President and Portfolio Manager at Harvard Management Company, Inc., Bacon Investments, at J. Aron, a division of Goldman Sachs, and at Cargill
Mr. Porter oversaw both trading and investment portfolios in energy in both the public and private sectors.
About ChampionX
ChampionX (formerly known as Apergy Corporation) is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies
drill for and produce oil and gas safely and efficiently around the world. ChampionX's products provide efficient functioning throughout the lifecycle of
2
a well - from drilling to completion to production. ChampionX's Chemical Technologies offering consist of chemistry solutions to maximize production from flowing oil and gas wells as well as
chemistry solutions used in drilling and completion activities. ChampionX's Production & Automation Technologies offerings consist of artificial lift equipment and solutions, including rod pumping systems, electric submersible pump
systems, progressive cavity pumps and drive systems and plunger lifts, as well as a full automation and digital offering consisting of equipment and software for Industrial Internet of Things ("IIoT") solutions for downhole monitoring,
wellsite productivity enhancement, and asset integrity management. ChampionX's Drilling Technologies offering provides market leading polycrystalline diamond cutters and bearings that result in cost effective and efficient drilling. To learn
more about ChampionX, visit our website at www.championX.com.
Forward-Looking Statements
This news release contains statements relating to future actions and results, which are "forward-looking statements" within the meaning of the
Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements relate to, among other things, ChampionX's market position and growth opportunities. Forward-looking statements
include, but are not limited to, statements related to ChampionX, ChampionX's expectations regarding the performance of the business, financial results, liquidity and capital resources of ChampionX, the effects of competition, and the effects
of future legislation or regulations and other
non-historical
statements. Forward-looking statements are subject to inherent risks and uncertainties that could cause actual results to differ materially from
current expectations, including, but not limited to, tax and regulatory matters; and changes in economic, competitive, strategic, technological, regulatory or other factors that affect the operation of ChampionX's businesses. You are
encouraged to refer to the documents that ChampionX files from time to time with the Securities and Exchange Commission (the "SEC"), including the "Risk Factors" in ChampionX's Annual Report on Form
10-K
for the year ended December 31, 2019, and in ChampionX's other filings with the SEC, for a discussion of these and other risks and uncertainties. Readers are cautioned not to place undue reliance on
ChampionX's forward-looking statements. Forward-looking statements speak only as of the day they are made and ChampionX undertakes no obligation to update any forward-looking statement, except as required by applicable law.
Investor Contact: David Skipper
david.skipper@apergy.com
713-230-8031
Media Contact: John Breed
john.breed@apergy.com
281-403-5751
3

text: Apergy

text: ChampionX

text: ChampionX

text: ChampionX

text: Apergy

text: ChampionX

text: ChampionX

text: Apergy Corporation

text: ChampionX

text: Apergy Corporation

text: ChampionX

text: Apergy Corporation

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: Apergy

text: ChampionX

text: Apergy Corporation

text: ChampionX

text: ChampionX

text: ChampionX

text: Apergy Corporation

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX

text: ChampionX


text:
EX-99.1
2
cmax-20210901ex99_1.htm
EX-99.1
EX-99.1
EX-99.1
CareMax Closes Acquisition of DNF Medical Centers
Miami, FL - Sept. 2, 2021 -- CareMax, Inc. ("CareMax") (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that it has closed the previously announced acquisition of DNF Medical Centers ("DNF"), a leading medical practice in the Orlando Metro area.
DNF operates six conveniently located medical centers serving approximately 4,000 Medicare Advantage members in its network. With this acquisition, CareMax now operates 42 medical centers, serving approximately 66,000 patients, including approximately 26,000 Medicare Advantage members. CareMax intends to use DNF as the foundation to further expand in the Central Florida and Tampa Bay region, a market with more than 2 million Medicare-eligible beneficiaries.
"We are excited to welcome the DNF physicians, patients and employees to the CareMax family and grow our presence in Central Florida by providing high-quality, compassionate care to seniors", said Carlos de Solo, Chief Executive Officer of CareMax. "This is an important acquisition for CareMax and is a step forward in executing our multi-pronged expansion strategy focused on de novo growth and strategic M&A".
CareMax plans to build upon DNF's track record of high-quality clinical care and member satisfaction, and accelerate the growth of the DNF network through multiple strategic avenues, including:

Working with the DNF leadership team to identify additional underserved communities in the Central Florida and Tampa Bay markets that would benefit from the CareMax model and new de novo buildouts;

Utilizing CareMax's proprietary technology platform, CareOptimize, to provide data, analytics and rules-based decision tools/workflows for DNF care teams to customize high-touch, whole person care and improve medical loss ratios; and

Driving further organic growth by utilizing CareMax's sales and marketing infrastructure and additional health plan relationships to fill existing patient capacity in DNF clinics (currently at less than 25% capacity).
The acquisition is expected to be immediately accretive.
About CareMax
CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CareMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Learn more at www.caremax.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and strategy. Words such as "anticipate", "believe", "budget", "contemplate", "continue", "could", "envision", "estimate", "expect", "guidance", "indicate", "intend", "may", "might", "plan", "possibly", "potential", "predict", "probably", "pro-forma", "project", "seek", "should", "target", or "will", or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, the Company's ability to expand its business and the business of DNF, including to fill existing patient capacity; the Company's ability to integrate DNF into the Company; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to the Company's services; the Company's ability to continue its growth; changes in laws and regulations applicable to the Company's business, in particular with respect to Medicare Advantage or Medicaid; the Company's ability to maintain its relationships with health plans and other key payers; the impact of COVID-19 or another pandemic, epidemic or outbreak of infectious disease on the Company's business and results of operation; and the Company's ability to recruit and retain qualified team members and independent physicians. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's reports filed with the SEC. All information provided in this press release is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law.
Contacts
CareMax, Inc.Gordon Carrollgordon.carroll@caremax.comRoger Ouroger.ou@caremax.com
Investor RelationsThe Equity Group Inc.Devin SullivanSenior Vice Presidentdsullivan@equityny.com(212) 836-9608

text: CareMax

text: DNF Medical Centers

text: CareMax, Inc.

text: CareMax

text: DNF Medical Centers

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax

text: CareMax


text:
EX-99.1
4
exhibit991march2016.htm
EXHIBIT 99.1
Exhibit
Exhibit 99.1
NEWS
TEAM, INC.
For immediate release
13131 Dairy Ashford, Suite 600
Contact: Greg L. Boane (281) 388-5541
Sugar Land, TX 77478
Team and Furmanite Announce Approval of Merger by Stockholders of Both Companies
SUGAR LAND, Texas and HOUSTON, Texas Feb. 25, 2016 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE:TISI) ("Team") and Furmanite Corporation (NYSE:FRM) ("Furmanite") today announced that stockholders of each of Team and Furmanite overwhelmingly approved their respective merger proposals related to the proposed combination of Furmanite and Team at their respective special meetings held earlier today.
More than 96% of the shares voting at the Furmanite special meeting voted in favor of the merger, and more than 99% of the shares voting at the Team special meeting voted in favor of the proposal to issue shares of Team common stock to Furmanite stockholders in connection with the merger.
Upon the consummation of the merger, Furmanite stockholders will have the right to receive 0.215 shares of Team common stock for each share of Furmanite common stock, with cash paid in lieu of fractional shares.
Team and Furmanite expect the closing of the transaction to occur promptly, subject to the satisfaction of all conditions.
About Team, Inc.
Headquartered near Houston, Texas, Team Inc. is a leading provider of specialty industrial services, including inspection and assessment, required in maintaining and installing high-temperature and high-pressure piping systems and vessels that are utilized extensively in the refining, petrochemical, power, pipeline and other heavy industries. Team offers these services in over 125 locations throughout the world. Team's common stock is traded on the New York Stock Exchange under the ticker symbol "TISI".
About Furmanite Corporation
Furmanite Corporation (NYSE:FRM), founded in 1920, is one of the world's largest specialty industrial services companies, providing world class solutions to customer needs through more than 80 offices on six continents. Furmanite delivers a wide portfolio of inspection and mechanical services which help monitor, maintain and renew the global energy, industrial and municipal infrastructures. World Headquarters and Global Support Operations are located in Houston, Texas; Rotterdam, Netherlands; Kendal, United Kingdom and Melbourne, Australia. For more information, visit www.furmanite.com.
1
Forward Looking Statements
This document contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Statements identified by words such as "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", "targets", "projects", "creates" or words of similar meaning generally are intended to identify forward-looking statements. These statements are based upon the current beliefs and expectations of Team's and Furmanite's management and are inherently subject to significant business, economic and competitive risks and uncertainties, many of which are beyond their respective control.
These forward-looking statements are subject to a number of factors, assumptions, risks and uncertainties which could cause Team's, Furmanite's or the combined company's actual results and experience to differ from the anticipated results and expectations expressed in such forward-looking statements, and such differences may be material. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change.
These factors, assumptions, risks and uncertainties include, but are not limited to: (1) conditions to the closing of the merger may not be satisfied, on the expected timeline or at all; (2) the transaction may involve unexpected costs, liabilities or delays; (3) the businesses of Team and Furmanite may not be integrated successfully or the integration may be more difficult, time-consuming or costly than expected; (4) the expected growth opportunities, cost savings or other benefits from the transaction may not be fully realized or may take longer to realize than expected; (5) revenues following the transaction may be lower than expected as a result of losses of customers or other reasons; (6) operating costs, customer loss and business disruption following the transaction, including difficulties in maintaining relationships with employees, may be greater than expected; (7) reputational risks and the reaction of the companies' customers to the transaction; (8) diversion of management time on merger-related issues; (9) customer acceptance of the combined company's products and services; (10) the outcome of any legal proceeding relating to the transaction; and (11) any changes in the strategy of Team, Furmanite or the anticipated strategy of the combined company. Additional factors that could cause Team's and Furmanite's results to differ materially from those described in the forward-looking statements can be found in Team's and Furmanite's reports (such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K) filed with the SEC and available at the SEC's website (www.sec.gov). All subsequent written and oral forward-looking statements concerning Team, Furmanite, or the proposed merger or other matters and attributable to Team, Furmanite or any person acting on either of their behalf are expressly qualified in their entirety by the cautionary statements above. Team and Furmanite do not undertake any obligation to update any forward-looking statement, whether written or oral, to reflect circumstances or events that occur after the date the forward-looking statements are made.
2

text: TEAM, INC.

text: Team, Inc.

text: Furmanite Corporation

text: Team, Inc.

text: Team Inc.

text: Furmanite Corporation

text: Furmanite Corporation


text:
EX-99.1
2
s103601_ex991.htm
EXHIBIT 99.1
B. Riley Financial
Completes Acquisition of United Online
LOS ANGELES, CA
-
July 1, 2016
-
B. Riley Financial, Inc. (NASDAQ:
RILY)
, a diversified provider of financial and business advisory services, has completed the acquisition of United Online,
Inc. (NASDAQ: UNTD), an Internet access and services provider.
B. Riley Financial acquired United Online for $11.00 per
share in a transaction valued at approximately $170 million.
As part of the transaction, Robert J. (Rusty) Taragan will be rejoining United Online as its CEO. Rusty previously spent 15
years at United Online, and its predecessor company NetZero, most recently as the President of its Communications Segment.
"The acquisition of United Online is consistent with
our plan of making financially prudent acquisitions that provide outsized risk-adjusted returns", said Bryant Riley, Chairman
and CEO of B. Riley Financial. "We look to benefit from the experience of United Online's seasoned employees and the
company's ability to achieve predictable recurring revenue and EBITDA, while operating the business to maximize free cash
flow for distribution to our shareholders".
"This acquisition represents an investment model we
intend to replicate over the long term-namely, purchasing companies with complex business dynamics in challenging or mature
industries and then implementing operational changes to generate attractive returns. By leveraging B. Riley Financial's broad
platform of services and capabilities, we believe we are ideally positioned to capitalize on additional investment opportunities
like United Online".
About United Online®
United Online, Inc., through its operating subsidiaries,
provides consumer subscription services and products, consisting of internet access services and devices, including dial-up, mobile
broadband, DSL, e-mail, Internet security, and web hosting services, under the NetZero and Juno brands. United Online is headquartered
in Woodland Hills, CA. For more information, visit www.unitedonline.net.
About B. Riley Financial, Inc.
B. Riley Financial, Inc. (NASDAQ: RILY) provides collaborative
financial services and solutions through several subsidiaries, including: B. Riley & Co. LLC, a leading investment bank which
provides corporate finance, research, and sales & trading to corporate, institutional and high net worth individual clients;
Great American Group, LLC, a leading provider of advisory and valuation services, and asset disposition and auction solutions;
B. Riley Capital Management, LLC, an SEC registered Investment Advisor, which includes B. Riley Asset Management, a provider of
investment products to institutional and high net worth investors, and B. Riley Wealth Management (formerly MK Capital Advisors),
a multi-family office practice and wealth management firm focused on the needs of ultra-high net worth individuals and families;
and Great American Capital Partners, a provider of senior secured loans and second lien secured loan facilities to middle market
public and private U.S. companies.
B. Riley Financial is headquartered in Los Angeles with
offices in major financial markets throughout the United States and Europe. For more information on B. Riley Financial, visit www.brileyfin.com.
1
Forward-Looking Statements
This press release may contain forward-looking statements
by B. Riley Financial that are not based on historical fact, including, without limitation, statements containing the words "expects,"
"anticipates", "intends", "plans", "believes", "seeks", "estimates"
and similar expressions and statements. Such forward looking statements include, but are not limited to, express or implied statements
regarding the acquisition and future financial performance, as well as statements regarding how management sees opportunities to
grow and broaden the firm. Because these forward-looking statements involve known and unknown risks and uncertainties, there are
important factors that could cause actual results, events or developments to differ materially from those expressed or implied
by these forward-looking statements. Such factors include our ability to achieve expected cost savings or other acquisition benefits,
in each case within expected time frames or at all; our ability to successfully integrate recent acquisitions, loss of key personnel,
our ability to manage growth, the potential loss of financial institution clients, the timing of completion of significant engagements,
and those risks described from time to time in B. Riley Financial's filings with the SEC, including, without limitation, the risks
described in B. Riley Financial's (f/k/a Great American Group, Inc.) Annual Report on Form 10-K for the year ended December 31,
2015 under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results
of Operations." These factors should be considered carefully and readers are cautioned not to place undue reliance on such
forward-looking statements. All information is current as of the date this press release is issued, and B. Riley Financial undertakes
no duty to update this information.
B. Riley Financial Investor Contact:
Scott Liolios
or
Matt
Glover
Liolios Group, Inc.
949-574-3860
RILY@liolios.com

text: B. Riley Financial

text: United Online

text: B. Riley Financial

text: United Online

text: B. Riley Financial

text: United Online

text: United Online

text: United Online

text: United Online

text: Bryant Riley

text: B. Riley Financial

text: United Online

text: B. Riley Financial

text: United Online

text: United Online

text: United Online

text: United Online

text: B. Riley Financial

text: B. Riley Financial

text: B. Riley Financial

text: B. Riley Financial

text: B. Riley Financial

text: B. Riley Financial

text: B. Riley Financial

text: B. Riley Financial

text: B. Riley Financial


text:
EX-99.1
2
file2.htm
PRESS RELEASE
Allied Healthcare International Inc. Divests Respiratory Therapy Division for $74.7 Million
Company Sets Course to Focus on Flexible Staffing and Homecare Services
NEW YORK--October 1, 2007-Allied Healthcare International Inc. (NASDAQ:
AHCI
-
News
), (AIM: AHI), a leading provider of healthcare staffing in the United Kingdom, announces the sale of its subsidiaries, Allied Respiratory Ltd. and Medigas Ltd., to Air Liquide Group (Paris:
AI
-
News
), a world leader in industrial and medical gases and related services, for approximately $74.7 million in cash. Allied Respiratory provides unified oxygen services including concentrators directly to customers in the South East of England and Northern Ireland as well as cylinder gases in Scotland.
The consideration is denominated in sterling and consists of an initial consideration of GBP 36.5 million with GBP 500,000 held back until certain conditions are met.
"As we move forward, Allied will continue to concentrate its efforts on expanding the Company's significant UK branch network, which provides Homecare Services and Flexible Staffing to local governments and Primary Care Trusts", commented Sarah L. Eames, Interim Chief Executive Officer and Deputy Chairman. "Allied is committed to providing a full spectrum of disease state management programs to sustain patient independence and mobility in the home. The Company has vetted and trained carers, nurses, and case managers, and develops individual care plans to meet the ever-changing patient requirements outside of the hospital setting. We are fully prepared to move forward with our mission to increase Allied's market share in the growing UK homecare services market".
David Moffatt, Allied Healthcare Chief Financial Officer, commented: "Allied will utilize the proceeds from the transaction to pay down debt and invest in information technology that will enable the company to more efficiently partner with local governments in patient care management. We are optimistic about the growing market potential that exists in the UK, and look forward to moving ahead with a significantly strengthened balance sheet".
About Allied Healthcare International Inc.
Allied Healthcare International Inc. (
http://www.alliedhealthcare.com
) is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of approximately one hundred branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of private patients, community care providers, nursing homes, and hospitals. For the nine months ended June 30, 2007, Allied Respiratory generated revenues of $19.4 million (GBP 9.9 million), operating profit of $4.9 million (GBP 2.5 million) and at that date had assets of $21.6 million (GBP 10.8 million).
FORWARD-LOOKING STATEMENTS
Certain statements contained in this news release may be forward-looking statements. These forward-looking statements are based on current expectations and projections about future events. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements include: Allied's ability to continue to recruit and retain qualified flexible healthcare staff; ability to enter into contracts with hospitals and other healthcare facility customers on terms attractive to Allied; the general level of patient occupancy at hospital and healthcare facilities of Allied's customers; dependence on the proper functioning of Allied's information systems; the effect of existing or future government regulation of the healthcare industry, and ability to
comply with these regulations; the impact of medical malpractice and other claims asserted against Allied; the effect of regulatory change that may apply to Allied and that may increase costs and reduce revenue and profitability; the ability to use net operating loss carry forwards to offset net income; the effect of the fluctuations in foreign currency exchange rates may have on our dollar denominated results of operations; and the impairment of goodwill, of which Allied has a substantial amount on the balance sheet, may have the effect of decreasing earnings or increasing losses. Other factors that could cause actual results to differ from those implied by the forward-looking statements in this press release include those described in Allied's most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. Allied undertakes no obligation to
publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Allied Healthcare International Inc.
David Moffatt, 20-7838-9922
Chief Financial Officer
davidmoffatt@alliedhealthcare.com
or
The Investor Relations Group
Adam Holdsworth, 212-825-3210
or
Rachel Colgate, 212-825-3210
or
Cenkos Securities plc (Nominated Adviser and Broker)
Ian Soanes, +44 (0)20-7397-8924

text: Allied Healthcare International Inc.

text: Allied Healthcare International Inc.

text: Allied Respiratory Ltd.

text: Medigas Ltd.

text: Air Liquide Group

text: Sarah L. Eames

text: Allied Healthcare International Inc.

text: Allied Healthcare International Inc.

text: Allied Healthcare International Inc.


text:
EX-99.2
3
pressrelease12-22x21.htm
EX-99.2
pressrelease12-22x21
Oportun completes acquisition of Digit, a neobanking company and platform SAN CARLOS, Calif., Dec. 22, 2021 - Oportun (Nasdaq:OPRT), a mission-driven fintech company announced today that it has completed the acquisition of Digit (digit.co), a neobanking platform that provides automated savings, investing, and banking tools. According to the company, the acquisition of Digit further expands its A.I. and digital capabilities to provide hardworking consumers a holistic offering built to address their financial needs. "This is a transformational deal that positions Oportun for even more future success", said Raul Vazquez, CEO of Oportun. "With this transaction, we are combining two mission-driven organizations with complementary services, capabilities, and member bases." Oportun acquired Digit for approximately $211.1 million, comprised of an aggregate of approximately $112.6 million in cash and approximately $98.5 million in Oportun common stock and/or restricted stock units to be settled in Oportun common stock on the basis of a price of $24.477 per share of Oportun common stock, determined at the time of signing pursuant to the definitive agreement between the parties. Oportun also closed a financing facility from Jefferies to finance the cash consideration. Digit is a neobanking platform founded in 2013 that provides its 600,000 paying members with personalized savings, investing and banking tools. Digit members can keep and integrate their existing bank accounts into the platform, or they can make Digit their primary banking relationship by opening new accounts via Digit's bank partner. Enabled by A.I., Digit automatically sets aside funds for members by analyzing cash flow and recognizing how much can be saved and invested today, while remaining well within a member's immediate financial means. Details Regarding the Acquisition Digit will operate as a business unit within Oportun and continue to be led by Digit founder and CEO, Ethan Bloch. All of Digit's 100+ employees have joined Oportun and will continue their job functions. J.P. Morgan served as exclusive financial advisor and Wilson Sonsini Goodrich & Rosati served as legal counsel to Oportun. Jefferies provided the financing facility. Goodwin Procter served as legal counsel to Digit. Financial Technology Partners served as exclusive strategic and financial advisor to Digit. An investor presentation related to the acquisition is available here.
Additional details and information about the terms and conditions of the acquisition will be available in a current report on Form 8-K to be filed by Oportun with the Securities and Exchange Commission. For more information about Oportun, visit www.oportun.com. For more information about Digit, visit www.digit.co. About Oportun Oportun (Nasdaq: OPRT) is a digital banking platform that uses A.I. to make financial health effortless for anyone. Oportun helps its 1.4 million members meet their daily borrowing, banking, savings, and investing needs. Since its inception, Oportun has provided more than $10 billion in responsible and affordable loans, and its members have set aside more than $7 billion for rainy days and other needs, saved more than $2 billion on interest and fees, and paid down more than $300 million in personal debt. In recognition of its responsibly designed products and mission to provide inclusive and affordable financial services that empower hardworking individuals to build a better future, Oportun has been certified as a Community Development Financial Institution (CDFI) since 2009. Forward-Looking Statements This communication contains forward-looking statements regarding Oportun's ("Oportun", "we" or "our") future business expectations which involve risks and uncertainties, including the expected opportunities and effects of the acquisition of Hello Digit, Inc. ("Digit") and the expectation that the acquisition of Digit will accelerate customer and revenue growth. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as "anticipate", "assume", "believe", "contemplate", "continue", "could", "estimate", "expect", "hope", "intend", "may", "might", "objective", "ongoing", "plan", "potential", "predict", "project", "should", "target", "will", or "would" or similar expressions and the negatives of those terms. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks, uncertainties and other factors relate to, among others: risks and uncertainties related to our acquisition of Digit, including the integration of the Digit business; failure to realize the expected benefits and synergies of the acquisition; the impact of the consummation of the acquisition on relationships with our and/or Digit's employees, customers, suppliers and other business partners; inability to retain key personnel; changes in legislation or government regulations affecting us or Digit; and economic, financial, social or political conditions that could adversely affect us or Digit. For additional information on other potential risks and uncertainties that could cause actual results to differ from the results predicted, please see our most recent Annual Report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. All forward-looking statements contained herein are made as of the date hereof. We undertake no duty to update this information unless required by law.
Media Contact George Gonzalez 650-769-0441 george.gonzalez@oportun.com Investor Contact Nils Erdmann 650-810-9074 ir@oportun.com

text: Oportun

text: Digit

text: Oportun

text: Digit

text: Digit

text: Oportun

text: Raul Vazquez

text: Oportun

text: Oportun

text: Digit

text: Oportun

text: Oportun

text: Oportun

text: Oportun

text: Jefferies

text: Digit

text: Digit

text: Digit

text: Digit

text: Digit

text: Digit

text: Oportun

text: Digit

text: Digit

text: Oportun

text: J.P. Morgan

text: Wilson Sonsini Goodrich & Rosati

text: Oportun

text: Jefferies

text: Goodwin Procter

text: Digit

text: Technology Partners

override: organization

text: Digit

text: Oportun

text: Oportun

text: Digit

text: Oportun

text: Oportun

text: Oportun

text: Oportun

text: Oportun

text: Oportun

text: Oportun

text: Hello Digit, Inc.

text: Digit

text: Digit

text: Digit

text: Digit

text: Digit

text: Digit

text: Digit


text:
EX-99.1
2
v387722_ex99-1.htm
PRESS RELEASE DATED AUGUST 25, 2014
FOR IMMEDIATE RELEASE
New York REIT, Inc. Acquires Twitter
Headquarters Building in Manhattan
New York, New York, August 25, 2014 - New York REIT, Inc.
("NYRT")
(NYSE: NYRT), a publicly traded real estate investment trust ("REIT"), announced today that it has closed its previously
announced acquisition of Twitter's headquarters in Manhattan located at 245-249 West 17
th
Street in the Chelsea
neighborhood.
The property, which includes a 12-story office tower combined
with an adjacent 6-story mixed use building, contains approximately 282,000 rentable square feet. In addition to Twitter, Room
& Board, Inc. occupies the retail portion of the building. Flywheel Sports, Inc. is also a tenant.
"We are extremely pleased to have closed our previously
announced acquisition of this flagship property strategically located in the heart of Chelsea's "Silicon Alley",
NYC's epicenter of creativity, technology, style, and energy" said New York REIT's President, Michael Happel.
Mr. Happel added, "The building is a beautiful, gut-renovation and contains two new lobbies along with brand new state-of-the-art
building systems, windows, elevators, and a stunning rooftop terrace that overlooks the Hudson River. Furthermore, we are excited
to have Twitter, one of the world's most coveted technology firms, as a core tenant".
About NYRT
NYRT is a publicly traded corporation listed on the NYSE and
is a New York City focused REIT that acquires income-producing commercial real estate, including office and retail properties,
in New York City. Additional information about NYRT can be found on its website at www.nyrt.com. NYRT may disseminate
important information regarding it and its operations, including financial information, through social media platforms such as
Twitter, Facebook and LinkedIn.
Forward Looking Statements
The statements in this press release that are not historical
facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the
outcome to be materially different. In addition, words such as "will", "should", "may", "anticipate,"
"believe", "expect" and "intend" indicate a forward-looking statement, although not all forward-looking
statements include these words. Actual results may differ materially from those contemplated by such forward-looking statements,
including those set forth in the Risk Factors section of NYRT's Annual Report on Form 10-K filed on February 28, 2014.
Further, forward-looking statements speak only as of the date they are made, and NYRT undertakes no obligation to update or revise
forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating
results over time, unless required by law.
Contacts
Anthony J. DeFazio
Michael A. Happel,
President
Gregory W. Sullivan,
CFO and COO
DDCworks
New York REIT, Inc.
New York REIT, Inc.
tdefazio@ddcworks.com
mhappel@arlcap.com
gsullivan@nyrt.com
(484) 342-3600
(212) 415-6500
(212) 415-6500
Andrew G. Backman, Managing Director
Investor Relations / Public Relations
RCS Capital Corporation
abackman@rcscapital.com
(917) 475-2135

text: New York REIT, Inc.

text: New York REIT, Inc.

text: Gregory W. Sullivan

text: New York REIT, Inc.

text: New York REIT, Inc.

text: Andrew G. Backman


text:
EX-99.1
4
a05-12372_1ex99d1.htm
EX-99.1
Exhibit 99.1
Think Partnership Acquires Real Estate School Online
Inc.
Accretive Merger Expected to Add Over $1.6 Million Annually to the
Company's Pre-Tax Income
NORTHBROOK,
Ill. - July 18, 2005 - In a move that will make CGI Holding Corporation
d/b/a Think Partnership Inc. (AMEX: THK
;
"Company") a major player in the growing field of online education, the Company
today announced that it has closed its acquisition of Real Estate School Online
Inc. ("Real Estate School Online").
Located
in Miami, Fla., Real Estate School Online is a leading provider of online
education products and services specializing in delivery of fully accredited
real estate licensing and continuing education courses. Already an industry
leader in Florida, Real Estate School Online has begun expanding its services
to other states. Perry Johannesburg, the president of Real Estate School
Online, will continue to serve in that capacity following the merger.
The Company has acquired all of the stock of Real
Estate School Online in exchange for $2.2 million in cash and CGI common stock with
an aggregate value of $2.2 million. Former shareholders of Real Estate School
Online will also be entitled to a one-time cash payment of up to $500,000 if
the pre-tax earnings of Real Estate School Online exceed specified targets
during the first twelve full calendar quarters following the closing. The
merger is expected to be immediately accretive to the earnings of Think
Partnership.
Gerard M. Jacobs, the Company's CEO, stated, "Real
Estate School Online is a growing and highly profitable company with a very
scalable business model. While we plan
to expand the Real Estate School Online services to other states, we expect
Real Estate School Online to realize over $1.6 million of pre-tax income over
the next twelve months without the benefit of our expansion plans or the
leverage that the marketing power of other Think subsidiaries will provide.
Perry Johannesburg is a very smart entrepreneur who is a great fit for our
growing partnership".
Scott Mitchell, the CEO of the Company's Cherish
subsidiary, added, "This merger is very much in line with Think Partnership's
strategy of bringing onboard companies that demonstrate consistent, strong
performance and that offer unique approaches to online services. Perry
Johannesburg's vision and leadership will serve as great assets to the parent
company and help assure continued growth and profitability".
"Real Estate School Online has experienced
tremendous growth of late and will one day have a national presence", said
Perry Johannesburg, president of Real Estate School Online. "Realizing
synergies with the many Think Partnership companies will position us well to
make that reality happen sooner than if we were going it alone. We fielded
purchase offers from many suitors, but in the end Think Partnership was the
best fit in terms of scope, expertise and complementary services".
The Company has begun doing business under the name "Think
Partnership Inc." and will seek formal shareholder approval to change its legal
name to Think Partnership Inc. later in 2005. The Company is based in
Northbrook, Ill. (see www.thinkpartnership.com) and currently has nine
subsidiaries: WebSourced, Inc., Morrisville, N.C., a leader in search
engine optimization and pay-per-click campaign management (see
www.websourced.com and www.keywordranking.com); MarketSmart Advertising, Inc.,
Rightstuff, Inc. d/b/a Bright Idea Studios, and Checkup Marketing, Inc.,
Raleigh, N.C., providing world-class off-line advertising, public relations,
marketing, branding and shopping evaluation services (see www.marketsmart.net,
www.brightideastudios.com and www.checkupmarketing.com); Cherish, Inc.,
Clearwater, Fla., a leading online dating company (see www.cherish.com); Ozona
Online Network, Inc., Clearwater, Fla., providing a comprehensive scope of
online services including start to finish web design, custom web based
applications, database systems, managed and shared hosting solutions,
e-commerce, and high-speed business Internet access (see www.ozline.net); KowaBunga!
Marketing, Inc., Westland, Mich., providing Internet marketing software
technologies, including software for affiliate marketing, search engine
marketing and opt-in email marketing (see www.kowabunga.com); PrimaryAds Inc.,
North Plainfield, NJ, a leading provider of affiliate
marketing services that connects website publishers with
online advertisers (see www.PrimaryAds.com); and
Real Estate School Online Inc., Miami, Fla., a leader in online education (see
www.RealEstateSchoolOnline.com). The Company has also entered into an agreement
to merge with privately-held Meandaur, Inc. d/b/a Proceed Interactive, a
full service marketing and communications agency with a core competency in
search marketing, which has offices in Chicago, Ill., Dallas, Texas and Los
Angeles, Calif. (see www.proceedinteractive.com); and has signed letters of
intent to acquire: Vintacom Media Group Inc., Edmonton, Alberta Canada, a
leading online dating company (see www.Vintacom.com); and Morex Marketing Group
LLC, a New York-based limited liability company and parent company of Internet
Web site www.babytobee.com.
Statements made in this press release that express
the Company's or management's intentions, plans, beliefs, expectations or
predictions of future events, are forward-looking statements. The words "believe,"
"expect", "intend", "estimate", "anticipate", "will" and similar expressions
are intended to further identify such forward-looking statements, although not
all forward-looking statements contain these identifying words. Those
statements are based on many assumptions and are subject to many known and
unknown risks, uncertainties and other factors that could cause the Company's
actual activities, results or performance to differ materially from those
anticipated or projected in such forward-looking statements. For a discussion
of these risks, see the Company's report on Form 10-QSB for the quarter
ended March 31, 2005 under the section headed "Management's
Discussion and Analysis of Financial Condition and Results of Operations - Risk
Factors." The Company cannot guarantee future financial results, levels of
activity, performance or achievements; and investors should not place undue
reliance on the Company's forward-looking statements. The forward-looking
statements contained herein represent the judgment of the Company as of the
date of this press release, and the Company expressly disclaims any intent,
obligation or undertaking to update or revise such forward-looking statements
to reflect any change in the Company's expectations with regard thereto or any
change in events, conditions or circumstances on which any such statements are
based.
Contact:
WordSmith Communications (for CGI Holding Corporation)
Glenna Musante, 800-849-2118 ext. 126
gmusante@marketsmart.net

text: Think Partnership

text:
Real Estate School Online
Inc

text: Think Partnership

text:
Real Estate School Online
Inc.

text: Perry Johannesburg

text:
Think
Partnership

text: Gerard M. Jacobs

text: Perry Johannesburg

text: Think Partnership

text:
Perry
Johannesburg

text: Perry Johannesburg

text: Think Partnership

text: Think Partnership

text:
Think
Partnership

text: Think Partnership

text: Real Estate School Online Inc.


text:
EX-99.1
4
v364039_ex99-1.htm
EXHIBIT 99.1
Innovus Pharmaceuticals,
Inc. Acquires Semprae Laboratories, Inc.
-
Adds Two Over the Counter Revenue-Generating Products, Zestra™ and Zestra Glide™, to its Female Sexual Health Product
Pipeline
LA
JOLLA, Calif., December 30, 2013 - Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company")
www.innovuspharma.com (OTC: BB: INNV) today announced that the Company acquired Semprae Laboratories, Inc. ("Semprae")
through a merger and for shares of common stock of Innovus Pharma. Semprae is a New Jersey company founded by women in 2008 with
the goal of improving women's sexual lives. From the beginning, Semprae has been marketing Zestra™,
the first non-prescription product clinically proven to increase arousal, sensation, pleasure and satisfaction in women. In 2011,
Semprae introduced Zestra Glide™, an accompanying water based lubricant. Together
the two products had gross sales of approximately $1 million in 2013.
Innovus
Pharma currently has two products targeting male sexual health including EjectDelay™
for premature ejaculation and CIRCUMserum™
to help alleviate reduced penile sensitivity
The
acquisition of Semprae brings a number of benefits to Innovus Pharma:
1.
Immediate
revenue-generating non-prescription products for women's sexual health. The Company
believes that Zestra™ is the only non-prescription product shown in published double-blind,
placebo-controlled clinical trials in close to 300 women in the U.S. to have a statistical
increase in desire, arousal and satisfaction in women with Female Sexual Arousal Disorder
("FSAD") with minimal side effects; Zestra™ is recommended by many
gynecologists, urologists and sex therapist due to its clinical efficacy and safety;
2.
Approximately $1 million in
new additional annual gross revenues from the sales of these products;
3.
Strong
intellectual property protection. Zestra™ is protected by patents extending to
beyond 2021;
4.
Immediate
retail presence in some of the largest U.S. retail chains such as Walmart, Target, K
Mart and Drugstore.com and large drug wholesalers such McKesson, Cardinal Health and
H.D. Smith;
5.
Over
85,000 retail customers for these two products; and
6.
Institutional
venture shareholders, including Quakers Partners, L.P. and Versant Ventures, L.P.
"This
acquisition of Semprae moves Innovus Pharma into the commercial revenue-generating stage with needed products in the female sexual
health space,"
said Dr.
Bassam Damaj, President and Chief Executive Officer
of Innovus Pharma. "In addition, it gives Innovus the needed retail infrastructure for distributing the rest of our OTC
products in the US. The combination of Semprae's two products with those of Innovus Pharma creates a company that is clearly
an emerging leader in the over the counter male and female sexual health space.
"
"The
synergy of Innovus Pharma's products in the male sexual health space including EjectDelay™ for premature ejaculation
and CIRCUMSerum™ to alleviate reduced penile sensitivity, with Semprae's products which target the female sexuality
area including Zestra™ for female sexual arousal and Zestra Glide™ as a lubricant, uniquely position
the Company in the sexual health category for further accelerated growth and expansion,"
said Adele C. Oliva, Partner at Quaker Partners, L.P., a Philadelphia life sciences venture fund and one of the two lead venture
investors in Semprae.
"The
expertise of the Innovus management team, including Dr. Damaj's past experience and success with other products in this
category when he was CEO of Apricus Biosciences, will be very valuable to grow the Semprae products in the U.S. and internationally,"
commented Camille Samuels, former Managing Partner and currently Affiliated Director at Versant Ventures, the other lead venture
investor in Semprae.
Dr.
Damaj added that Innovus Pharma expects to acquire or develop more products to treat male or female sexual health.
About Zestra™ and Glide™
and Female Sexual Arousal
Zestra™
is a patented blend of natural oils clinically-proven in double-blind placebo-controlled clinical trials in close to 300 women
to increase in a statistical significant manner the arousal, desire and satisfaction in FSAD women. The product has been on the
U.S. Canadian markets for approximately five years through major retailers such as Walmart, Target and K-Mart and drug wholesalers
such as McKesson, Cardinal Health and HD Smith and through online sales. Zestra Glide™ is an accompanying water-based lubricant
developed and sold by Semprae. For more information visit
www.zestra.com
To date, no
product has been approved in the U.S. to treat FSAD, a persistent or recurring inability to attain or maintain adequate sexual
excitement until the completion of a sexual activity. The diagnosis can also refer to an inadequate lubrication-swelling response
normally present during arousal and sexual activity causing personal distress. Published papers on the FSAD market size estimate
it to be equal or larger than the market for erectile dysfunction in males, and possibly larger.
About EjectDelay™ and Premature
Ejaculation
EjectDelay™
is an over-the-counter ("OTC") U.S. Food and Drug Administration and Health Canada compliant proprietary topical treatment
containing the drug benzocaine and indicated for delay of premature ejaculation ("PE"). The drug typically works within
minutes of application to the glans of the penis. In clinical trials, the application of benzocaine has been shown to delay premature
ejaculation by several minutes. For more information visit
www.ejectdelay.com
.
PE is the most
common sexual dysfunction reported by men but is still under-diagnosed and under-treated. PE can happen at any age and its prevalence
is consistent across all ages. In an article in
The Journal of Sexual Medicine
in 2007 Sex Med 2007, D.L. Patrick, D. Rowland
and M. Rothman state,
"Global studies consistently report
that 20-30% of men experience PE worldwide. This means that PE is experienced at similar rates across the globe".
About CIRCUMserum
TM
and Reduced Penile Sensitivity
Innovus Pharma
acquired the ex-U.S. rights to CIRCUMserum
TM
from Centric Research Institute (CRI) in early 2013. Reduced Penile Sensitivity
("RPS") refers to the condition of decreased sensation in the penis during sexual activity. Subjects with RPS report
difficulty in stimulating the penis, maintaining erection, and/or achieving orgasm. The duration of intercourse is typically prolonged
due to delayed orgasm.
Normal ejaculation
is quantified and diagnosed by the time it takes a man to ejaculate from penetrating the vagina. Normal men will ejaculate between
4-8 minutes following penetration of the vagina. Loss of sensation in the penis will cause men to ejaculate after longer than
15 minutes and may take up to 30 minutes, with some never being able to ejaculate.
CIRCUMserum
TM
is an all-natural cream with the active medicinal excipient cinnamon oil (cinnamaldehyde) at 0.75%. CIRCUMserum
TM
activates the TRPA1 channels, leading to exciting the nociceptive responsive nerve endings to increase penile sensitivity without
affecting the thickness of the skin. For more information visit
www.circumserum.com
.
About Innovus
Pharmaceuticals, Inc.
Innovus Pharma,
headquartered in La Jolla, California, is an emerging pharmaceuticals company that delivers innovative and uniquely presented
and packaged health solutions through its over-the-counter medicines and consumer and health products.
For more information,
go to
www.innovuspharma.com
.
INNOVUS
PHARMA'S FORWARD-LOOKING Safe Harbor
Statements
under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in
this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually
or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including,
but not limited to, receiving patent protection for any of its products, receiving approval or to be compliant with the requirements
of any relevant regulatory authority relating to such products, to successfully commercialize or maintain the sales of such products
as Zestra™ and Zestra Glide
TM
and to achieve its other development, commercialization and financial objectives
and to fully integrate Semprae into the Company. Readers are cautioned not to place undue reliance on these forward-looking statements
as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the
risk factors set forth in the Company's most recent annual report on Form 10-K, subsequent quarterly reports filed on Form 10-Q
and other filings made with the SEC. Copies of these reports are available from the SEC's website or without charge from the Company.
###
Innovus
Pharma Contact:
Kevin Holmes
Chesapeake
Group
info@chesapeakegp.com
T: 410-825-3930

text:
Innovus Pharmaceuticals,
Inc.

text: Semprae Laboratories, Inc.

text: Innovus Pharmaceuticals, Inc.

text: Innovus Pharma

text: Semprae Laboratories, Inc.

text: Semprae

text: Innovus Pharma

text: Semprae

text: Semprae

text: Semprae

text:
Innovus
Pharma

text: Semprae

text: Innovus Pharma

text: Semprae

text: Innovus Pharma

text: Bassam Damaj

text: Innovus Pharma

text: Semprae

text: Innovus Pharma

text: Innovus Pharma

text: Semprae

text: Adele C. Oliva

text: Semprae

text: Semprae

text: Semprae

text: Innovus Pharma

text: Semprae

text: Innovus Pharma

text:
Innovus
Pharmaceuticals, Inc.

text: Innovus Pharma

text:
INNOVUS
PHARMA

text: Semprae

text:
Innovus
Pharma